Skip to main content
. 2020 Oct 21;21(20):7802. doi: 10.3390/ijms21207802

Figure 2.

Figure 2

Cell viability of MCF-7 (A) and MDA-MB-231 (B) cells after 72 h of incubation with ipilimumab under different condition (high glucose; low glucose; high glucose + empagliflozin at 500 nM; switch high glucose to low glucose); (C) Cell viability of AC16 cells after 72 h of incubation with ipilimumab under different condition (high glucose; low glucose; high glucose + empagliflozin at 500 nM; shifting from a high glucose to low glucose). Error bars depict means ± SD (n = 3). Statistical analysis was performed using paired t-test.